ThreatMetrix®, a LexisNexis® Risk Solutions Company, empowers the global economy to grow profitably and securely without compromise. With deep insight into 1.4 billion anonymized user identities, ThreatMetrix ID™ delivers the intelligence behind 100 million daily authentication and trust decisions, to differentiate legitimate customers from fraudsters in real time.
ThreatMetrix is recognized as the sole Leader in the 2017 Forrester Wave™ for risk-based authentication. Learn more at www.threatmetrix.com.
Datacastle is a provider of enterprise endpoint backup services focused on enhancing data security for mobile workforces. Its flagship product, Datacastle RED, offers a comprehensive solution that safeguards critical information on laptops, tablets, and smartphones through features such as data backup, recovery, encryption, and secure data shredding in the event of loss or theft. The platform supports both self-management by end users and centralized management by IT departments, allowing organizations to enforce data policies and maintain compliance. Datacastle RED is available as a hosted solution on Microsoft Azure or through on-premise implementation. The company, founded in 2005 and based in Seattle, Washington, has been recognized in the Gartner Hype Cycle for Storage Technologies and continues to provide scalable and efficient data protection for enterprises.
Pathway Therapeutics is focused on the discovery and development of best in class isoform selective inhibitors of PI3-kinase (PI3K) for the treatment of cancer and inflammatory diseases in targeted patient populations most likely to benefit.
Mantara is focused on enhancing securities trading through the provision of advanced technology solutions designed for integrated multi-asset trading and analytics. The company aims to transform the trading landscape for equities, options, and futures by addressing the growing demand for efficiency, transparency, and functionality in the market. By developing innovative solutions that surpass existing standards, Mantara is committed to reshaping how these financial instruments are traded globally.
Datacastle is a provider of enterprise endpoint backup services focused on enhancing data security for mobile workforces. Its flagship product, Datacastle RED, offers a comprehensive solution that safeguards critical information on laptops, tablets, and smartphones through features such as data backup, recovery, encryption, and secure data shredding in the event of loss or theft. The platform supports both self-management by end users and centralized management by IT departments, allowing organizations to enforce data policies and maintain compliance. Datacastle RED is available as a hosted solution on Microsoft Azure or through on-premise implementation. The company, founded in 2005 and based in Seattle, Washington, has been recognized in the Gartner Hype Cycle for Storage Technologies and continues to provide scalable and efficient data protection for enterprises.
ThreatMetrix®, a LexisNexis® Risk Solutions Company, empowers the global economy to grow profitably and securely without compromise. With deep insight into 1.4 billion anonymized user identities, ThreatMetrix ID™ delivers the intelligence behind 100 million daily authentication and trust decisions, to differentiate legitimate customers from fraudsters in real time.
ThreatMetrix is recognized as the sole Leader in the 2017 Forrester Wave™ for risk-based authentication. Learn more at www.threatmetrix.com.
Pathway Therapeutics is focused on the discovery and development of best in class isoform selective inhibitors of PI3-kinase (PI3K) for the treatment of cancer and inflammatory diseases in targeted patient populations most likely to benefit.
CHF Solutions, Inc. is a medical device company specializing in the development and commercialization of therapies for patients with fluid overload and heart failure. Its primary product, the Aquadex FlexFlow System, provides temporary ultrafiltration treatment for patients who have not responded to diuretics, as well as extended treatment for those requiring hospitalization. The system comprises a console, a disposable blood set, and a catheter, and is marketed to hospitals and clinics in the United States and various international markets through a combination of direct sales and specialty distributors. Additionally, the company has developed the C-Pulse Heart Assist System, which employs balloon counter-pulsation technology to aid the heart's function in patients with Class III and ambulatory Class IV heart failure. This minimally invasive device aims to alleviate symptoms, enhance mobility, and improve overall quality of life for patients. Founded in 1999 and headquartered in Eden Prairie, Minnesota, CHF Solutions was previously known as Sunshine Heart, Inc. before rebranding in 2017.
Datacastle is a provider of enterprise endpoint backup services focused on enhancing data security for mobile workforces. Its flagship product, Datacastle RED, offers a comprehensive solution that safeguards critical information on laptops, tablets, and smartphones through features such as data backup, recovery, encryption, and secure data shredding in the event of loss or theft. The platform supports both self-management by end users and centralized management by IT departments, allowing organizations to enforce data policies and maintain compliance. Datacastle RED is available as a hosted solution on Microsoft Azure or through on-premise implementation. The company, founded in 2005 and based in Seattle, Washington, has been recognized in the Gartner Hype Cycle for Storage Technologies and continues to provide scalable and efficient data protection for enterprises.
Dilithium Networks specializes in delivering high-quality multimedia content over mobile and broadband networks to various devices. The company is recognized for its innovative mobile video solutions, boasting extensive deployments in 60 countries that reach over 1 billion subscribers. Dilithium has played a pioneering role in mobile video communications, with its solutions utilized by leading network operators, content owners, and aggregators across various network types, including 2G, 3G, and WiFi. By focusing on comprehensive multimedia delivery, Dilithium aims to enhance user experiences in an increasingly digital world.
Pathway Therapeutics is focused on the discovery and development of best in class isoform selective inhibitors of PI3-kinase (PI3K) for the treatment of cancer and inflammatory diseases in targeted patient populations most likely to benefit.
ThreatMetrix®, a LexisNexis® Risk Solutions Company, empowers the global economy to grow profitably and securely without compromise. With deep insight into 1.4 billion anonymized user identities, ThreatMetrix ID™ delivers the intelligence behind 100 million daily authentication and trust decisions, to differentiate legitimate customers from fraudsters in real time.
ThreatMetrix is recognized as the sole Leader in the 2017 Forrester Wave™ for risk-based authentication. Learn more at www.threatmetrix.com.
Mantara is focused on enhancing securities trading through the provision of advanced technology solutions designed for integrated multi-asset trading and analytics. The company aims to transform the trading landscape for equities, options, and futures by addressing the growing demand for efficiency, transparency, and functionality in the market. By developing innovative solutions that surpass existing standards, Mantara is committed to reshaping how these financial instruments are traded globally.
Piedmont Pharmaceuticals LLC is a specialty pharmaceutical development and marketing company established in 2001 and located in Greensboro, North Carolina. The company focuses on therapeutics for both human and animal health, and it out-licenses product marketing rights to strategic pharmaceutical partners on a domestic and global scale. Piedmont Pharmaceuticals is dedicated to producing innovative and user-friendly products while ensuring efficient market entry at minimal costs.
Datacastle is a provider of enterprise endpoint backup services focused on enhancing data security for mobile workforces. Its flagship product, Datacastle RED, offers a comprehensive solution that safeguards critical information on laptops, tablets, and smartphones through features such as data backup, recovery, encryption, and secure data shredding in the event of loss or theft. The platform supports both self-management by end users and centralized management by IT departments, allowing organizations to enforce data policies and maintain compliance. Datacastle RED is available as a hosted solution on Microsoft Azure or through on-premise implementation. The company, founded in 2005 and based in Seattle, Washington, has been recognized in the Gartner Hype Cycle for Storage Technologies and continues to provide scalable and efficient data protection for enterprises.
Xumii is a mobile application provider based in San Mateo, California, established in 2006. The company specializes in creating a mobile social address book and social networking platform that enables users to connect with friends across various social networks, including Facebook, MySpace, and imeem. In addition to its social networking capabilities, Xumii integrates instant messaging services such as AIM, Yahoo!, MSN Live, and GoogleTalk, allowing users to communicate seamlessly. As of September 2009, Xumii operates as a subsidiary of Myriad Group AG.
Mantara is focused on enhancing securities trading through the provision of advanced technology solutions designed for integrated multi-asset trading and analytics. The company aims to transform the trading landscape for equities, options, and futures by addressing the growing demand for efficiency, transparency, and functionality in the market. By developing innovative solutions that surpass existing standards, Mantara is committed to reshaping how these financial instruments are traded globally.
Pathway Therapeutics is focused on the discovery and development of best in class isoform selective inhibitors of PI3-kinase (PI3K) for the treatment of cancer and inflammatory diseases in targeted patient populations most likely to benefit.
AdGent Digital is a media and technology company that works with leading publishers to deliver brands a premium audience via proprietary display, social media, and tablet advertising platforms. AdGent Digital has offices in USA, Europe, and Asia and delivers brand messages to audiences in countries around the world.
ThreatMetrix®, a LexisNexis® Risk Solutions Company, empowers the global economy to grow profitably and securely without compromise. With deep insight into 1.4 billion anonymized user identities, ThreatMetrix ID™ delivers the intelligence behind 100 million daily authentication and trust decisions, to differentiate legitimate customers from fraudsters in real time.
ThreatMetrix is recognized as the sole Leader in the 2017 Forrester Wave™ for risk-based authentication. Learn more at www.threatmetrix.com.
UiActive is a mobile phone solution that can be updated dynamically from the network
Piedmont Pharmaceuticals LLC is a specialty pharmaceutical development and marketing company established in 2001 and located in Greensboro, North Carolina. The company focuses on therapeutics for both human and animal health, and it out-licenses product marketing rights to strategic pharmaceutical partners on a domestic and global scale. Piedmont Pharmaceuticals is dedicated to producing innovative and user-friendly products while ensuring efficient market entry at minimal costs.
Xumii is a mobile application provider based in San Mateo, California, established in 2006. The company specializes in creating a mobile social address book and social networking platform that enables users to connect with friends across various social networks, including Facebook, MySpace, and imeem. In addition to its social networking capabilities, Xumii integrates instant messaging services such as AIM, Yahoo!, MSN Live, and GoogleTalk, allowing users to communicate seamlessly. As of September 2009, Xumii operates as a subsidiary of Myriad Group AG.
Altiris Therapeutics
Series B in 2007
Altiris Therapeutics develops and commercializes drugs to treat metastatic cancer. The company offers CXCR4 receptor, which acts as a mediator of cellular and chemical trafficking; and Emtriva, which is used for the treatment of HIV Infection. Altiris Therapeutics was founded in 2005 and is based in Atlanta, Georgia.
Mantara is focused on enhancing securities trading through the provision of advanced technology solutions designed for integrated multi-asset trading and analytics. The company aims to transform the trading landscape for equities, options, and futures by addressing the growing demand for efficiency, transparency, and functionality in the market. By developing innovative solutions that surpass existing standards, Mantara is committed to reshaping how these financial instruments are traded globally.
Dilithium Networks specializes in delivering high-quality multimedia content over mobile and broadband networks to various devices. The company is recognized for its innovative mobile video solutions, boasting extensive deployments in 60 countries that reach over 1 billion subscribers. Dilithium has played a pioneering role in mobile video communications, with its solutions utilized by leading network operators, content owners, and aggregators across various network types, including 2G, 3G, and WiFi. By focusing on comprehensive multimedia delivery, Dilithium aims to enhance user experiences in an increasingly digital world.
The intellectual property portfolio of bCODE is now owned by Mobile Technology Holdings Ltd.
Dilithium Networks specializes in delivering high-quality multimedia content over mobile and broadband networks to various devices. The company is recognized for its innovative mobile video solutions, boasting extensive deployments in 60 countries that reach over 1 billion subscribers. Dilithium has played a pioneering role in mobile video communications, with its solutions utilized by leading network operators, content owners, and aggregators across various network types, including 2G, 3G, and WiFi. By focusing on comprehensive multimedia delivery, Dilithium aims to enhance user experiences in an increasingly digital world.
Dilithium Networks specializes in delivering high-quality multimedia content over mobile and broadband networks to various devices. The company is recognized for its innovative mobile video solutions, boasting extensive deployments in 60 countries that reach over 1 billion subscribers. Dilithium has played a pioneering role in mobile video communications, with its solutions utilized by leading network operators, content owners, and aggregators across various network types, including 2G, 3G, and WiFi. By focusing on comprehensive multimedia delivery, Dilithium aims to enhance user experiences in an increasingly digital world.
As of October 2010, Phenomix closed down as it was unable to find a partner to pay for is clinical trial bills after Forest Laboratories walked away. Phenomix is a drug discovery and development company building a portfolio of novel therapeutics for the treatment of major human diseases. Phenomix' lead clinical candidate, PHX1149, is a DPP4 inhibitor in phase 2 testing as a once daily oral treatment for type 2 diabetes. Phenomix' second program is directed at the treatment of hepatitis C through inhibition of the NS3/4A viral protease. Phenomix is based in San Diego, California.